2000
From microbial genome sequence to applications
WEINSTOCK, G.M., David ŠMAJS, J. HARDHAM a S.J- NORRISZákladní údaje
Originální název
From microbial genome sequence to applications
Autoři
WEINSTOCK, G.M., David ŠMAJS, J. HARDHAM a S.J- NORRIS
Vydání
Res. Microbiol. 2000
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10600 1.6 Biological sciences
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Organizační jednotka
Lékařská fakulta
Změněno: 24. 1. 2003 13:14, prof. MUDr. David Šmajs, Ph.D.
Anotace
V originále
Whole genome sequences of microbial pathogens present new opportunities for clinical applications. Chief among these are development of antimicrobials, diagnostics, and vaccines. While antimicrobial development is a more difficult, long-term prospect, new diagnostics and vaccines are likely to be the first products of microbial genomics. To take advantage of whole genome sequences, methods for production of gene products in surrogate hosts (heterologous expression) are required that will work for large-scale, high-throughput gene expression. This will allow genomic information from even the most experimentally difficult pathogens to be mined for applications. In addition, screening methods to test gene products for their potential as vaccine candidates are needed for large-scale screening. These areas for technological development should be stimulated by the potential for converting genomic sequence information into applications.